224 related articles for article (PubMed ID: 23460379)
21. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
[TBL] [Abstract][Full Text] [Related]
22. Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.
Link H; Nietsch J; Kerkmann M; Ortner P;
Support Care Cancer; 2016 Jan; 24(1):367-376. PubMed ID: 26081593
[TBL] [Abstract][Full Text] [Related]
23. [A general description of the clinical guideline for the management of febrile neutropenia].
Takamatsu Y
Gan To Kagaku Ryoho; 2013 Jun; 40(6):697-702. PubMed ID: 23863646
[TBL] [Abstract][Full Text] [Related]
24. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
25. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
[TBL] [Abstract][Full Text] [Related]
26. Development of pediatric oncology supportive care indicators: Evaluation of febrile neutropenia care in the north of the Netherlands.
Ten Berg S; Loeffen EAH; van de Wetering MD; Martens DHJ; van Ede CM; Kremer LCM; Tissing WJE
Pediatr Blood Cancer; 2019 Feb; 66(2):e27504. PubMed ID: 30318786
[TBL] [Abstract][Full Text] [Related]
27. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
Tuffaha HW; Treish IM; Zaru L
J Oncol Pharm Pract; 2008 Sep; 14(3):131-8. PubMed ID: 18524866
[TBL] [Abstract][Full Text] [Related]
28. Clinical practice guidelines for children with cancer presenting with fever to the emergency room.
Pakakasama S; Surayuthpreecha K; Pandee U; Anurathapan U; Maleewan V; Udomsubpayakul U; Butthep P; Santanirand P; Sirachainan N; Hongeng S
Pediatr Int; 2011 Dec; 53(6):902-5. PubMed ID: 21418423
[TBL] [Abstract][Full Text] [Related]
29. Febrile neutropenia in EDs: the role of an electronic clinical practice guideline.
Lim C; Bawden J; Wing A; Villa-Roel C; Meurer DP; Bullard MJ; Rowe BH
Am J Emerg Med; 2012 Jan; 30(1):5-11, 11.e1-5. PubMed ID: 21030183
[TBL] [Abstract][Full Text] [Related]
30. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.
Ahn S; Lee YS; Chun YH; Kwon IH; Kim W; Lim KS; Kim TW; Lee KH
Support Care Cancer; 2011 Aug; 19(8):1151-8. PubMed ID: 20552376
[TBL] [Abstract][Full Text] [Related]
33. G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.
Link H; Kerkmann M; Holtmann L; Ortner P;
Support Care Cancer; 2019 Apr; 27(4):1459-1469. PubMed ID: 30374765
[TBL] [Abstract][Full Text] [Related]
34. Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines.
Naeem D; Alshamrani MA; Aseeri MA; Khan MA
Pharmacy (Basel); 2018 Aug; 6(3):. PubMed ID: 30103459
[No Abstract] [Full Text] [Related]
35. Going local: Evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital.
Liu R; Gitman MR; Morris AM; So M
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e3. PubMed ID: 36714288
[TBL] [Abstract][Full Text] [Related]
36. Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer.
Olson J; Mehra S; Hersh AL; Thorell EA; Stoddard GJ; Maese L; Barnette PE; Lemons RS; Pavia AT; Knackstedt ED
J Pediatric Infect Dis Soc; 2021 Feb; 10(1):27-33. PubMed ID: 32092134
[TBL] [Abstract][Full Text] [Related]
37. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care.
Raghavendra M; Hoeg RT; Bottner WA; Agger WA
WMJ; 2014 Apr; 113(2):53-8. PubMed ID: 24908899
[TBL] [Abstract][Full Text] [Related]
38. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
Heuser M; Ganser A; Bokemeyer C; ; ;
Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
[TBL] [Abstract][Full Text] [Related]
39. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
Aapro MS; Cameron DA; Pettengell R; Bohlius J; Crawford J; Ellis M; Kearney N; Lyman GH; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
Eur J Cancer; 2006 Oct; 42(15):2433-53. PubMed ID: 16750358
[TBL] [Abstract][Full Text] [Related]
40. Febrile neutropenia and its associated hospitalization in breast cancer patients on docetaxel-containing regimen: A retrospective cohort study on duration of prophylactic GCSF administration.
Lee CF; Zhou K; Young WM; Wong CS; Ng TY; Lee SF; Leung K; Wong LKM; So KH; Tang W; Chong G; Chan SK; Yip YTE; Ma VYM; Yeung A; Chin CHY; Kwan MW; Tsang HT
Support Care Cancer; 2020 Aug; 28(8):3801-3812. PubMed ID: 31832822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
